Institutional Ownership
Biodexa Pharmaceuticals PLC
CUSIP 59564R880SPONSORED ADSBDRXQ1 2026
13D / 13G Filings
3
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
10.0%
Max % of class reported
Institutional Holders
7
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
3 filings · latest Feb 17, 2026
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Sabby Management, LLC | 257.5K | $159.1K |
| 2 | Armistice Capital, LLC | 97.5K | $60.3K |
| 3 | Gamma Investing LLC | 13.8K | $8.5K |
| 4 | Ubs Group AG | 127 | $78 |
| 5 | Hilton Head Capital Partners, LLC | 30 | $19 |
| 6 | Rhumbline Advisers | 19 | $11 |
| 7 | Caitong International Asset Management Co., Ltd | 1 | $1 |